-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Arch Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2020 to Q2 2024.
- Arch Therapeutics, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $1.05M, a 2.41% increase year-over-year.
- Arch Therapeutics, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $4.87M, a 6.25% decline year-over-year.
- Arch Therapeutics, Inc. annual Costs and Expenses for 2023 was $5.12M, a 10.6% decline from 2022.
- Arch Therapeutics, Inc. annual Costs and Expenses for 2022 was $5.72M, a 10.4% decline from 2021.
- Arch Therapeutics, Inc. annual Costs and Expenses for 2021 was $6.39M, a 19.4% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)